Findl Oliver, Buehl Wolf, Bauer Peter, Sycha Thomas
Department of Ophthalmology, Hanusch Hospital, Heinrich-Collin-Strasse 30, Vienna, Austria, A-1140.
Cochrane Database Syst Rev. 2010 Feb 17;2010(2):CD003738. doi: 10.1002/14651858.CD003738.pub3.
Posterior capsule opacification (PCO) remains the most common long-term complication after cataract surgery. It can be treated by Nd:YAG laser capsulotomy, however this may lead to other complications and laser treatment is not available in large parts of the developing world. Therefore, many studies try to find factors influencing the development of PCO.
To summarise the effects of different interventions to inhibit PCO. These include modifications of surgical technique and intraocular lens (IOL) design, implantation of additional devices and pharmacological interventions.
We searched CENTRAL, MEDLINE, EMBASE, LILACS in March 2009 and reference lists of identified trial reports.
We included only prospective, randomised and controlled trials with a follow-up time of at least 12 months. Interventions included modifications in surgical technique explicitly to inhibit PCO, modifications in IOL design (material and geometry), implantation of additional devices and pharmacological therapy compared to each other, placebo or standard treatment.
We extracted data and entered it into RevMan. We compared visual acuity data, PCO scores and YAG capsulotomy rates and performed a meta-analysis when possible.
Sixty six studies were included in the review. The review was divided into three parts. 1. Influence of IOL optic material on the development of PCO. There was no significant difference in PCO development between the different IOL materials (PMMA, hydrogel, hydrophobic acrylic, silicone) although hydrogel IOLs tend to have higher PCO scores and silicone IOLs lower PCO scores than the other materials. 2. Influence of IOL optic design on the development of PCO. There was a significantly lower PCO score (-8.65 (-10.72 to -6.59), scale 0 to 100) and YAG rate (0.19 (0.11 to 0.35)) in sharp edged than in round edged IOLs, however not between 1-piece and 3-piece IOLs. 3. Influence of surgical technique and drugs on the development of PCO. There was no significant difference between different types of intraoperative/postoperative anti-inflammatory treatment except for treatment with an immunotoxin (MDX-A) which led to a significantly lower PCO rate.
AUTHORS' CONCLUSIONS: Due to the highly significant difference between round and sharp edged IOL optics, IOLs with sharp (posterior) optic edges should be preferred. There is no clear difference between optic materials. The choice of postoperative anti-inflammatory treatment does not seem to influence PCO development.
后囊膜混浊(PCO)仍然是白内障手术后最常见的远期并发症。它可以通过钕:钇铝石榴石激光囊切开术进行治疗,然而这可能会导致其他并发症,并且在发展中世界的大部分地区无法进行激光治疗。因此,许多研究试图找出影响PCO发生发展的因素。
总结不同干预措施抑制PCO的效果。这些措施包括手术技术的改进、人工晶状体(IOL)设计的改进、额外装置的植入以及药物干预。
我们于2009年3月检索了Cochrane中心对照试验注册库(CENTRAL)、医学索引数据库(MEDLINE)、荷兰医学文摘数据库(EMBASE)、拉丁美洲和加勒比地区卫生科学数据库(LILACS)以及已识别试验报告的参考文献列表。
我们仅纳入随访时间至少为12个月的前瞻性、随机对照试验。干预措施包括明确为抑制PCO而对手术技术的改进、IOL设计(材料和几何形状)的改进、额外装置的植入以及相互比较、与安慰剂或标准治疗相比的药物治疗。
我们提取数据并录入RevMan软件。我们比较了视力数据、PCO评分和钇铝石榴石激光囊切开术发生率,并在可能的情况下进行了荟萃分析。
本综述纳入了66项研究。该综述分为三个部分。1. IOL光学材料对PCO发生发展的影响。不同IOL材料(聚甲基丙烯酸甲酯、水凝胶、疏水性丙烯酸酯、硅酮)之间PCO的发生发展无显著差异,尽管水凝胶IOL的PCO评分往往高于其他材料,而硅酮IOL的PCO评分低于其他材料。2. IOL光学设计对PCO发生发展的影响。锐边IOL的PCO评分(-8.65(-10.72至-6.59),评分范围0至100)和钇铝石榴石激光囊切开术发生率(0.19(0.11至0.35))显著低于圆边IOL,但一体式和三件式IOL之间无差异。3. 手术技术和药物对PCO发生发展的影响。除了用免疫毒素(MDX - A)治疗导致PCO发生率显著降低外,不同类型的术中/术后抗炎治疗之间无显著差异。
由于圆边和锐边IOL光学设计之间存在高度显著差异,应首选具有锐(后)光学边缘的IOL。光学材料之间没有明显差异。术后抗炎治疗的选择似乎不影响PCO的发生发展。